| HERON THERAPEUTICS, INC. /DE/ |
Director |
Common Stock |
8,753,290 |
$13,129,935 |
$1.50 |
08 Aug 2025 |
By Velan Capital Master Fund LP |
| HERON THERAPEUTICS, INC. /DE/ |
Director |
Common Stock |
69,777 |
$154,904 |
$2.22 |
08 Aug 2025 |
Direct |
| HERON THERAPEUTICS, INC. /DE/ |
Director |
Stock Option (Right to Buy) |
35,900 |
$62,107 |
$1.73 |
31 Jan 2025 |
Direct |
| ALIMERA SCIENCES INC |
Director, 10%+ Owner |
Common Stock |
0 |
$0 |
$3.83 |
16 Sep 2024 |
By Velan Capital Master Fund LP |
| ALIMERA SCIENCES INC |
Director, 10%+ Owner |
Common Stock |
0 |
$0 |
$3.83 |
16 Sep 2024 |
By Velan Capital SPV I LLC |
| HERON THERAPEUTICS, INC. /DE/ |
Director |
Series A Convertible Preferred Stock |
70,012 |
|
|
08 Aug 2025 |
By Velan Capital Master Fund LP |
| ALIMERA SCIENCES INC |
Director, 10%+ Owner |
Stock Option (Right to Buy) |
0 |
|
|
16 Sep 2024 |
Direct |
| ALIMERA SCIENCES INC |
Director, 10%+ Owner |
Warrants |
0 |
|
|
16 Sep 2024 |
By Velan Capital Master Fund LP |